Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

Europe sets out to reform its clinical trial rules

Nature Reviews Drug Discovery volume 11, pages 660–661 (2012)Cite this article

Subjects

A proposal to replace widely criticized trial regulations could boost European drug development, if key details can be sorted out.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Daniel Cressey
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cressey, D. Europe sets out to reform its clinical trial rules. Nat Rev Drug Discov 11, 660–661 (2012). https://doi.org/10.1038/nrd3843

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3843

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research